{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T21:59:55Z","timestamp":1776722395255,"version":"3.51.2"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["contemporaryclinicaltrials.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.cct.2016.03.002","type":"journal-article","created":{"date-parts":[[2016,3,8]],"date-time":"2016-03-08T23:00:50Z","timestamp":1457478050000},"page":"376-382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Optimizing operational efficiencies in early phase trials: The Pediatric Trials Network experience"],"prefix":"10.1016","volume":"47","clinical-trial-number":[{"clinical-trial-number":"nct01431326","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01670136","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01728363","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01994993","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Amanda","family":"England","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Wade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Brian","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Berezny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Laughon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cct.2016.03.002_bb0005","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1542\/peds.60.1.91","article-title":"Guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations","volume":"60","author":"American Academy of Pediatrics Committee on Drugs","year":"1977","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.cct.2016.03.002_bb0010","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1542\/peds.2013-4060","article-title":"Off-label use of drugs in children","volume":"133","author":"Frattarelli","year":"2014","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.cct.2016.03.002_bb0015","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1136\/adc.2008.149898","article-title":"Ethical issues of clinical trials in children: a European perspective","volume":"94","author":"Sammons","year":"2009","journal-title":"Arch. Dis. Child."},{"issue":"5","key":"10.1016\/j.cct.2016.03.002_bb0020","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1586\/ecp.11.43","article-title":"Innovative clinical trial design for pediatric therapeutics","volume":"4","author":"Laughon","year":"2011","journal-title":"Expert. Rev. Clin. Pharmacol."},{"issue":"11","key":"10.1016\/j.cct.2016.03.002_bb0025","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1128\/AAC.00569-08","article-title":"Population pharmacokinetics of fluconazole in young infants","volume":"52","author":"Wade","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.cct.2016.03.002_bb0030","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/clpt.2009.200","article-title":"Safety and pharmacokinetics of repeat-dose micafungin in young infants","volume":"87","author":"Benjamin","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.cct.2016.03.002_bb0035","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/INF.0b013e3181910e2d","article-title":"Pharmacokinetics of an elevated dosage of micafungin in premature neonates","volume":"28","author":"Smith","year":"2009","journal-title":"Pediatr. Infect. dis. J."},{"issue":"4","key":"10.1016\/j.cct.2016.03.002_bb0040","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1128\/AAC.06071-11","article-title":"Population pharmacokinetics of metronidazole evaluated using scavenged samples from preterm infants","volume":"56","author":"Cohen-Wolkowiez","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.cct.2016.03.002_bb0045","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/clpt.2011.26","article-title":"Safety and pharmacokinetics of multiple-dose anidulafungin in infants and neonates","volume":"89","author":"Cohen-Wolkowiez","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.cct.2016.03.002_bb0050","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/FTD.0b013e3182587665","article-title":"Population pharmacokinetics of piperacillin using scavenged samples from preterm infants","volume":"34","author":"Cohen-Wolkowiez","year":"2012","journal-title":"Ther. Drug Monit."},{"issue":"4","key":"10.1016\/j.cct.2016.03.002_bb0055","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1021\/ac8022839","article-title":"Dried blood spots as a sample collection technique for the determination of pharmacokinetics in clinical studies: considerations for the validation of a quantitative bioanalytical method","volume":"81","author":"Spooner","year":"2009","journal-title":"Anal. Chem."},{"issue":"9","key":"10.1016\/j.cct.2016.03.002_bb0060","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/INF.0b013e3182947cf8","article-title":"Determining population and developmental pharmacokinetics of metronidazole using plasma and dried blood spot samples from premature infants","volume":"32","author":"Cohen-Wolkowiez","year":"2013","journal-title":"Pediatr. Infect. dis. J."},{"issue":"5","key":"10.1016\/j.cct.2016.03.002_bb0065","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1128\/AAC.02139-13","article-title":"Developmental pharmacokinetics of piperacillin and tazobactam using plasma and dried blood spots from infants","volume":"58","author":"Cohen-Wolkowiez","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"10.1016\/j.cct.2016.03.002_bb0070","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/INF.0b013e31819f1f50","article-title":"Fluconazole dosing for the prevention or treatment of invasive candidiasis in young infants","volume":"28","author":"Wade","year":"2009","journal-title":"Pediatr. Infect. dis. J."},{"issue":"5","key":"10.1016\/j.cct.2016.03.002_bb0075","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/INF.0b013e318202cbb3","article-title":"Fluconazole loading dose pharmacokinetics and safety in infants","volume":"30","author":"Piper","year":"2011","journal-title":"Pediatr. Infect. dis. J."},{"issue":"10","key":"10.1016\/j.cct.2016.03.002_bb0080","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1097\/INF.0b013e31825d3091","article-title":"Pharmacokinetics and safety of fluconazole in young infants supported with extracorporeal membrane oxygenation","volume":"31","author":"Watt","year":"2012","journal-title":"Pediatr. Infect. dis. J."},{"issue":"9","key":"10.1016\/j.cct.2016.03.002_bb0085","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/INF.0b013e31825d2fa2","article-title":"Pharmacokinetics and tolerability of single-dose daptomycin in young infants","volume":"31","author":"Cohen-Wolkowiez","year":"2012","journal-title":"Pediatr. Infect. dis. J."},{"issue":"10","key":"10.1016\/j.cct.2016.03.002_bb0090","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/INF.0b013e31822e8b0b","article-title":"Population pharmacokinetics of meropenem in plasma and cerebrospinal fluid of infants with suspected or complicated intra-abdominal infections","volume":"30","author":"Smith","year":"2011","journal-title":"Pediatr. Infect. dis. J."},{"issue":"1","key":"10.1016\/j.cct.2016.03.002_bb0095","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/01.inf.0000435509.75114.3d","article-title":"Population pharmacokinetics of intravenous acyclovir in preterm and term infants","volume":"33","author":"Sampson","year":"2014","journal-title":"Pediatr. Infect. dis. J."},{"issue":"S1","key":"10.1016\/j.cct.2016.03.002_bb0100","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/14767058.2011.607667","article-title":"Neonatal hyponatremia: differential diagnosis and treatment","volume":"24","author":"Marcialis","year":"2011","journal-title":"J. Matern. Fetal Neonatal Med."},{"issue":"12","key":"10.1016\/j.cct.2016.03.002_bb0105","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1440-1754.2006.00975.x","article-title":"Hypernatraemia in preterm infants born at less than 27weeks gestation","volume":"42","author":"Gawlowski","year":"2006","journal-title":"J. Paediatr. Child Health"},{"issue":"10","key":"10.1016\/j.cct.2016.03.002_bb0110","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1542\/pir.30-10-412","article-title":"Hypernatremia","volume":"30","author":"Goff","year":"2009","journal-title":"Pediatr. Rev."},{"key":"10.1016\/j.cct.2016.03.002_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005257.pub3","article-title":"Interventions for non-oliguric hyperkalaemia in preterm neonates","volume":"5","author":"Vemgal","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"issue":"5","key":"10.1016\/j.cct.2016.03.002_bb0120","first-page":"516","article-title":"Serum ionized calcium concentrations in normal neonates","volume":"142","author":"Loughead","year":"1988","journal-title":"Am. J. Dis. Child."},{"issue":"3","key":"10.1016\/j.cct.2016.03.002_bb0125","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/jp.2010.82","article-title":"Elevation in plasma creatinine and renal failure in premature neonates without major anomalies: terminology, occurrence and factors associated with increased risk","volume":"31","author":"Walker","year":"2011","journal-title":"J. Perinatol."},{"issue":"3","key":"10.1016\/j.cct.2016.03.002_bb0130","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1542\/peds.2010-3851","article-title":"Postnatal glucose homeostasis in late-preterm and term infants","volume":"127","author":"Adamkin","year":"2011","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.cct.2016.03.002_bb0135","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1542\/peds.2006-0628","article-title":"Hyperglycemia is a risk factor for early death and morbidity in extremely low birth-weight infants","volume":"118","author":"Hays","year":"2006","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.cct.2016.03.002_bb0140","doi-asserted-by":"crossref","first-page":"F144","DOI":"10.1136\/adc.2008.152454","article-title":"Plasma aminotransferase concentrations in preterm infants","volume":"96","author":"Victor","year":"2011","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"issue":"4","key":"10.1016\/j.cct.2016.03.002_bb0145","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000335240","article-title":"Serum magnesium in the first week of life in extremely low birth weight infants","volume":"101","author":"Noone","year":"2012","journal-title":"Neonatology"},{"issue":"5","key":"10.1016\/j.cct.2016.03.002_bb0150","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1055\/s-0031-1274506","article-title":"Risk assessment for adverse outcome in term and late preterm neonates with bilirubin values of 20mg\/dL or more","volume":"28","author":"Weng","year":"2011","journal-title":"Am. J. Perinatol."},{"issue":"1","key":"10.1016\/j.cct.2016.03.002_bb0155","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.1111\/jpc.12053","article-title":"Prognostic value of biochemical liver parameters in neonatal sepsis-associated cholestasis","volume":"49","author":"Oswari","year":"2013","journal-title":"J. Paediatr. Child Health"},{"issue":"2","key":"10.1016\/j.cct.2016.03.002_bb0160","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1891\/0730-0832.29.2.109","article-title":"The complete blood count","volume":"29","author":"Milcic","year":"2010","journal-title":"Neonatal Netw."},{"issue":"2","key":"10.1016\/j.cct.2016.03.002_bb0165","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1542\/peds.2008-2654","article-title":"Reference ranges for hematocrit and blood hemoglobin concentration during the neonatal period: data from a multihospital health care system","volume":"123","author":"Jopling","year":"2009","journal-title":"Pediatrics"},{"issue":"Suppl. 1","key":"10.1016\/j.cct.2016.03.002_bb0170","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3109\/14767058.2011.607577","article-title":"Evidence-based platelet transfusion recommendations in neonates","volume":"24","author":"Del Vecchio","year":"2011","journal-title":"J. Matern. Fetal Neonatal Med."},{"issue":"2","key":"10.1016\/j.cct.2016.03.002_bb0175","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/jp.2008.141","article-title":"Platelet reference ranges for neonates, defined using data from over 47,000 patients in a multihospital healthcare system","volume":"29","author":"Wiedmeier","year":"2009","journal-title":"J. Perinatol."},{"issue":"12","key":"10.1016\/j.cct.2016.03.002_bb0180","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/MPH.0b013e3181c29c25","article-title":"Fresh frozen plasma and recombinant factor VIIa use in neonates","volume":"31","author":"Puetz","year":"2009","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"6","key":"10.1016\/j.cct.2016.03.002_bb0185","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0022-3476(99)70096-X","article-title":"Serum anion gap in the differential diagnosis of metabolic acidosis in critically ill newborns","volume":"135","author":"Lorenz","year":"1999","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.cct.2016.03.002_bb0190","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0009-9120(98)00084-8","article-title":"Pediatric reference ranges for creatine kinase, CKMB, troponin I, iron, and cortisol","volume":"32","author":"Soldin","year":"1999","journal-title":"Clin. Biochem."},{"issue":"214","key":"10.1016\/j.cct.2016.03.002_bb0195","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/adc.40.214.645","article-title":"Serial acid\u2013base determinations in normal premature and full-term infants during the first 72hours of life","volume":"40","author":"Malan","year":"1965","journal-title":"Arch. Dis. Child."},{"issue":"12","key":"10.1016\/j.cct.2016.03.002_bb0200","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/sj.jp.7211613","article-title":"A simple presurgical necrotizing enterocolitis-mortality scoring system","volume":"26","author":"Kessler","year":"2006","journal-title":"J. Perinatol."},{"issue":"1","key":"10.1016\/j.cct.2016.03.002_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000658-197801000-00001","article-title":"Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging","volume":"187","author":"Bell","year":"1978","journal-title":"Ann. Surg."},{"issue":"4","key":"10.1016\/j.cct.2016.03.002_bb0210","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1055\/s-0028-1103514","article-title":"Understanding clinical literature relevant to spontaneous intestinal perforations","volume":"26","author":"Gordon","year":"2009","journal-title":"Am. J. Perinatol."},{"issue":"5","key":"10.1016\/j.cct.2016.03.002_bb0215","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/WNP.0b013e31826bd90d","article-title":"Neonatal seizures and status epilepticus","volume":"29","author":"Abend","year":"2012","journal-title":"J. Clin. Neurophysiol."},{"issue":"4","key":"10.1016\/j.cct.2016.03.002_bb0220","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0022-3476(78)80282-0","article-title":"Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm","volume":"92","author":"Papile","year":"1978","journal-title":"J. Pediatr."},{"issue":"6","key":"10.1016\/j.cct.2016.03.002_bb0225","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1542\/peds.2011-3028","article-title":"Mortality and neonatal morbidity among infants 501 to 1500 grams from 2000 to 2009","volume":"129","author":"Horbar","year":"2012","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.cct.2016.03.002_bb0230","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jpeds.2004.03.034","article-title":"Ultrasound abnormalities preceding cerebral palsy in high-risk preterm infants","volume":"144","author":"De Vries","year":"2004","journal-title":"J. Pediatr."},{"issue":"3","key":"10.1016\/j.cct.2016.03.002_bb0235","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1542\/peds.97.3.336","article-title":"Blood pressure ranges in premature infants: II. The first week of life","volume":"97","author":"Hegyi","year":"1996","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.cct.2016.03.002_bb0240","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/FJC.0b013e3181d86525","article-title":"Repolarization abnormalities in the newborn","volume":"55","author":"Schwartz","year":"2010","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"7","key":"10.1016\/j.cct.2016.03.002_bb0245","doi-asserted-by":"crossref","first-page":"e339","DOI":"10.1542\/neo.6-7-e339","article-title":"Neonatal supraventricular tachycardia (SVT)","volume":"6","author":"Singh","year":"2005","journal-title":"NeoReviews"},{"issue":"7","key":"10.1016\/j.cct.2016.03.002_bb0250","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/01.inf.0000168742.98617.66","article-title":"Epidemiology and diagnosis of hospital-acquired conjunctivitis among neonatal intensive care unit patients","volume":"24","author":"Haas","year":"2005","journal-title":"Pediatr. Infect. dis. J."},{"issue":"1","key":"10.1016\/j.cct.2016.03.002_bb0255","first-page":"59","article-title":"Risk factors associated with unilateral hearing loss","volume":"139","author":"Yelverton","year":"2013","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.cct.2016.03.002_bb0260","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaci.2005.12.1303","article-title":"Second symposium on the definition and management of anaphylaxis: summary report\u2014second national institute of allergy and Infectious disease\/food allergy and anaphylaxis network symposium","volume":"117","author":"Sampson","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cct.2016.03.002_bb0265","unstructured":"Eunice Kennedy Shriver National Institute of Child Health and Human Development: http:\/\/bpca.nichd.nih.gov\/about\/pages\/index.aspx. (Accessed July 20, 2015)."},{"key":"10.1016\/j.cct.2016.03.002_bb0270","unstructured":"Pediatric Trials Network: http:\/\/pediatrictrials.org\/. (Accessed July 20, 2015)."},{"key":"10.1016\/j.cct.2016.03.002_bb0275","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01431326?term=pops&rank=3. (Accessed July 20, 2015)."},{"key":"10.1016\/j.cct.2016.03.002_bb0280","unstructured":"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01670136?term=sildenafil&rank=2. (Accessed July 20, 2015)."},{"key":"10.1016\/j.cct.2016.03.002_bb0285","unstructured":"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01728363?term=Pharmacokinetics+of+ antistaphylococcal+antibiotics+in+infants&rank=1. (Accessed July 20, 2015)."},{"key":"10.1016\/j.cct.2016.03.002_bb0290","unstructured":"Federal Register: https:\/\/www.federalregister.gov\/articles\/2015\/05\/28\/2015-12848\/pediatric-studies-of-meropenem-conducted-in-accordance-with-the-public-health-service-act. (Accessed July 20, 2015)."},{"key":"10.1016\/j.cct.2016.03.002_bb0295","unstructured":"Food and Drug Administration: http:\/\/www.fda.gov\/downloads\/Drugs\/\u2026\/Guidances\/UCM227351.pdf. (Accessed July 20, 2015)."},{"key":"10.1016\/j.cct.2016.03.002_bb0300","series-title":"Toxicity Tables\u2013DMID Toxicity Tables [Internet]","year":"2011"},{"key":"10.1016\/j.cct.2016.03.002_bb0305","series-title":"Common Toxicity Criteria Manual, version 2.0.","year":"1999"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714416300283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714416300283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T15:14:58Z","timestamp":1655219698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714416300283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":61,"alternative-id":["S1551714416300283"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2016.03.002","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing operational efficiencies in early phase trials: The Pediatric Trials Network experience","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2016.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}